Oncternal Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Oncternal Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Oncternal Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 2.96M shares, a 95% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.96M -56M -95% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 2.96M -55.8M -95% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 2.96M -55.8M -95% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.95M +74K +2.58% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 59M +3.45M +6.22% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 58.7M +6.58M +12.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 58.7M +9.28M +18.8% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 2.87M -46.6M -94.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 55.5M +6.09M +12.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 52.2M +2.77M +5.6% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 49.4M +63K +0.13% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 49.4M +627K +1.29% Dec 31, 2021 10-K 2023-03-09
Q3 2021 49.4M +27.1M +121% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 49.4M +32M +185% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 49.4M +34M +221% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 48.8M +33.4M +217% Dec 31, 2020 10-K 2022-03-10
Q3 2020 22.3M +6.96M +45.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 17.3M +1.97M +12.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 15.4M -8.66M -36% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 15.4M +11.6M +309% Dec 31, 2019 10-K/A 2021-03-12
Q3 2019 15.4M -8.66M -36% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 15.4M -8.66M -36% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 24.1M +1.52M +6.76% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 3.76M -17.8M -82.5% Dec 31, 2018 10-K 2020-03-16
Q3 2018 24.1M +2.51M +11.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 24M +7.99M +49.8% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 22.5M +6.49M +40.4% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 21.5M +5.62M +35.3% Dec 31, 2017 10-K 2019-03-18
Q3 2017 21.5M -120M -84.8% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 16M -126M -88.7% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 16M -126M -88.7% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 15.9M +1.88M +13.4% Dec 31, 2016 10-K 2018-03-13
Q3 2016 142M +1.54M +1.1% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 142M +1.38M +0.98% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 142M +1.38M +0.98% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 14M -126M -90% Dec 31, 2015 10-K 2017-03-24
Q3 2015 140M +64.4M +84.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 140M +64.4M +84.7% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 140M +65.2M +86.8% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 140M +77.1M +122% Dec 31, 2014 10-K 2016-03-15
Q3 2014 76M +12.8M +20.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 76M +12.9M +20.4% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 75.2M +12.3M +19.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 63.2M +367K +0.58% Dec 31, 2013 10-K 2015-03-16
Q3 2013 63.2M +368K +0.59% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 63.1M +301K +0.48% Jun 30, 2013 10-Q 2013-07-22
Q1 2013 62.9M +90.1K +0.14% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 62.8M +28.2K +0.05% Dec 31, 2012 10-K 2014-03-12
Q3 2012 62.8M +26.7K +0.04% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 62.8M +53.3K +0.09% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 62.8M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 62.8M +11.1M +21.4% Dec 31, 2011 10-K 2013-03-05
Q3 2011 62.8M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 62.8M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 51.7M Dec 31, 2010 10-K 2012-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.